MoVe-IT III Annual Meeting

Advancing Particle Therapy requires models for biologically optimized treatment planning systems (TPS) in ion beam therapy, and dedicated devices for plan verification, allowing validation accounting for a wide range of complex physical and biological effects.

The MoVe IT project (INFN Call group V) aims at exploiting both modeling and verification methods for ion beam TPS with a main focus on RBE, biological impact of nuclear  fragmentation (including target fragments)  and intra-tumor heterogeneity.